Fluconaz 200 mg (Fluconazole)

Fluconaz 200mg (Fluconazole): Complete Medical Guide — Uses, Dosage, Side Effects & Precautions 

Regulatory Note: Fluconaz 200mg contains Fluconazole 200mg, a synthetic triazole antifungal. The originator branded product, Diflucan (Pfizer), has been FDA-approved since the 1990s for vaginal, oropharyngeal, esophageal, and systemic candidiasis, as well as cryptococcal meningitis. Fluconaz is a generic formulation containing the identical active molecule. It is a prescription-only medication for most of its approved indications, though single-dose formulations for vaginal candidiasis are available over-the-counter in some markets. 

Fluconaz 200mg is a prescription antifungal tablet containing Fluconazole 200mg, a member of the triazole class of antifungal drugs. It is FDA-approved for the treatment of a specific, defined list of fungal infections — vaginal candidiasis, oropharyngeal and esophageal candidiasis, systemic Candida infections, Candida urinary tract infections and peritonitis, and cryptococcal meningitis — as well as for prophylaxis of candidiasis in bone marrow transplant recipients. 

A critical safety issue with a claim in the source content: One reviewed document states that “long-term use of Fluconaz 200mg Tablet is safe when monitored by a healthcare professional” as a blanket FAQ answer. This overstates the actual safety picture. Fluconazole carries documented risks of hepatotoxicity, QT-interval prolongation (including a published case of torsades de pointes), and — critically — is a potent inhibitor of multiple cytochrome P450 enzymes (CYP2C9, CYP2C19, and CYP3A4), creating the potential for numerous serious drug interactions, several of which are absolutely contraindicated. “Safe when monitored” is not an accurate blanket statement without the specific monitoring, interaction screening, and dose-duration context detailed throughout this guide.

What is Fluconaz 200mg?  

Fluconaz 200mg is a tablet formulation of Fluconazole, a synthetic triazole antifungal agent with a broader spectrum of activity than earlier imidazole antifungals. It is distinguished pharmacokinetically from many other antifungals by being cleared primarily via renal excretion as unchanged drug — meaning, unlike drugs cleared mainly by the liver, fluconazole dosing must be adjusted for kidney function in multi-dose regimens (see Dosage table below), a detail entirely absent from the source content. 

Fluconazole has an elimination half-life of approximately 30 hours, which is why it is typically dosed only once daily and why a loading dose (twice the daily maintenance dose) is recommended on the first day of multi-dose therapy — this achieves plasma concentrations close to steady-state by the second day, rather than requiring several days to build up gradually. Notably, the enzyme-inhibiting effect of fluconazole on other drugs persists for 4 to 5 days after the drug itself is stopped, due to this long half-life — an important practical point for managing drug interactions around the time fluconazole therapy ends. 

How Does Fluconaz 200mg Work? 

Mechanism of Action 

Fluconazole works by inhibiting the fungal cytochrome P450 enzyme lanosterol 14α-demethylase (CYP51), which is essential for the conversion of lanosterol to ergosterol — the primary sterol component that maintains the structural integrity and function of the fungal cell membrane. By blocking ergosterol synthesis, fluconazole causes accumulation of methylated sterol precursors, disrupting the cell membrane’s structure and function. This ultimately inhibits fungal growth and reproduction — the source content’s description of this mechanism is broadly accurate, though it omits the specific enzyme target (CYP51/lanosterol demethylase), which is the basis for fluconazole’s selectivity (fungal CYP51 differs from human cholesterol-synthesis enzymes, though not perfectly, which is part of why some human drug interactions occur via the related human CYP450 system). 

Uses and FDA-Approved Indications of Fluconaz 200mg 

1. Vaginal Candidiasis 

Treated with a single 150mg oral dose — notably not the 200mg strength discussed in this specific guide. This is an important dosing distinction: patients should not assume the 200mg tablet is appropriate for this indication without specific physician guidance, as the standard regimen uses a different strength entirely. 

2. Oropharyngeal and Esophageal Candidiasis 

Both conditions use a 200mg loading dose on Day 1, followed by 100mg once daily. Esophageal candidiasis, being typically more severe, requires a longer minimum treatment course (3 weeks, and at least 2 weeks past symptom resolution) compared to oropharyngeal disease (minimum 2 weeks). 

3. Systemic Candida Infections 

Including candidemia, disseminated candidiasis, and Candida pneumonia. The FDA label notes that the optimal therapeutic dose and duration for these infections have not been formally established through large controlled trials — treatment is based on clinical judgement, with doses up to 400mg daily used in available data. 

4. Candida Urinary Tract Infections and Peritonitis 

Treated with daily doses of 50–200mg based on clinical response, per open-label study data referenced in the FDA label. 

5. Cryptococcal Meningitis 

For acute treatment: a 400mg loading dose on Day 1, followed by 200mg once daily, continued for 10 to 12 weeks after cerebrospinal fluid (CSF) culture becomes negative. In AIDS patients specifically, ongoing maintenance therapy is typically required to prevent relapse — this is a chronic suppressive use, not a finite course, which the source content does not distinguish from acute treatment. 

6. Bone Marrow Transplant Prophylaxis 

Fluconazole is also FDA-approved to reduce the incidence of candidiasis in patients undergoing bone marrow transplantation who are receiving cytotoxic chemotherapy or radiation therapy — a preventive rather than treatment use, correctly gestured at but not detailed in the source content. 

 Dosage and Administration of Fluconaz 200mg 

 

Indication / Scenario	FDA-Approved Dosing Regimen
Vaginal candidiasis	150 mg as a SINGLE oral dose (not a daily regimen)
Oropharyngeal candidiasis (oral thrush)	200 mg loading dose Day 1, then 100 mg once daily for at least 2 weeks
Esophageal candidiasis	200 mg loading dose Day 1, then 100 mg once daily (up to 400 mg/day); minimum 3 weeks and 2 weeks past symptom resolution
Candida urinary tract infection / peritonitis	50–200 mg once daily
Systemic candidiasis (candidemia, disseminated, pneumonia)	Up to 400 mg once daily; optimal dose/duration not formally established
Cryptococcal meningitis — acute treatment	400 mg loading dose Day 1, then 200 mg once daily for 10–12 weeks after CSF culture is negative
Cryptococcal meningitis — AIDS relapse suppression	200 mg once daily (long-term maintenance)
Bone marrow transplant prophylaxis	Per treating physician; established prophylactic indication
Renal impairment (multi-dose therapy)	Full loading dose regardless of renal function, then reduce maintenance dose based on creatinine clearance
Haemodialysis patients	100% of dose after each dialysis session; reduced dose on non-dialysis days

 How to Take Fluconaz 200mg 

• Take once daily, orally, with or without food — food does not significantly affect absorption 
• Oral absorption is rapid and almost complete, which is why the oral dose is identical to the intravenous dose for equivalent therapeutic effect 
• Complete the full prescribed course, even if symptoms improve — inadequate treatment duration is the most common cause of recurrence 
• Do not double a dose to make up for one that was missed 

Missed Dose 

Take the missed dose as soon as you remember, but do not double up on your next dose to compensate for one that was skipped. 

Overdose 

Symptoms of fluconazole overdose have historically included hallucinations and paranoid behaviour in reported cases. If an overdose is suspected, seek medical attention immediately — supportive care and, if recent, gastric lavage may be considered by treating clinicians. 

Cardiac Risk — QT Prolongation (Missing from Source Content) 

This is a serious risk category entirely absent from the reviewed source content. Fluconazole can directly prolong the QT interval by inhibiting the hERG cardiac potassium channel and disrupting its normal trafficking — an effect that is amplified when combined with other QT-prolonging drugs. 

The first published case report of fluconazole-associated torsades de pointes (a life-threatening arrhythmia) appeared in 1999: a 59-year-old woman with cirrhosis and fungal peritonitis developed a QTc of 606 milliseconds (a dangerously prolonged interval; normal is typically under 450ms) while on intravenous and intraperitoneal fluconazole, with a measured serum fluconazole concentration nearly 10 times the therapeutic range. Her QT interval normalized over several weeks after the drug was discontinued, with no other identifiable cause present. 

This risk is why fluconazole has absolute contraindications with several specific medications (cisapride, terfenadine, astemizole, pimozide, quinidine, erythromycin) and requires caution with others (amiodarone) — detailed fully in the Drug Interactions section below. 

 Side Effects of Fluconaz 200mg 

Common Side Effects 

• Nausea, vomiting, diarrhoea, abdominal pain
• Headache 
• Dizziness
• Altered taste sensation
• Rash, itching, or hives 

Liver Function Abnormalities 

The source content correctly notes liver enzyme elevation and recommends monitoring, but does not specify what this monitoring should involve or how frequently it should occur — this depends on treatment duration and dose, and should be individualised by the prescribing physician, particularly for courses exceeding 2 weeks or doses above 200mg/day. 

Serious Side Effects — Seek Immediate Medical Attention 

• Severe skin reactions: Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported (correctly flagged in the source content). Any severe rash, blistering, or skin peeling requires immediate medical evaluation and drug discontinuation. 
• Cardiac arrhythmia: Palpitations, fainting, or irregular heartbeat may indicate QT prolongation or torsades de pointes — seek emergency care (see Cardiac Risk section above). 
• Severe hepatotoxicity: Yellowing of the skin or eyes, dark urine, or severe abdominal pain may indicate significant liver injury and require immediate evaluation. 
• Anaphylaxis and angioedema: Swelling of the face, lips, tongue, or throat, or difficulty breathing, requires emergency treatment. 

 Drug Interactions 

The source content mentions drug interactions only in the vaguest general terms (“blood thinners, epilepsy medications, some antibiotics”). This substantially understates the scope and severity of fluconazole’s interaction profile, which arises from its role as a moderate CYP3A4/CYP2C9 inhibitor and a strong CYP2C19 inhibitor. Notably, this inhibitory effect is dose-dependent and becomes clinically significant at doses of 200mg/day or higher in patients with normal renal function — precisely the dose covered in this guide. 

 

Drug	Clinical Action	Mechanism / Risk
Cisapride, terfenadine, astemizole, pimozide, quinidine	ABSOLUTE CONTRAINDICATION	Serious cardiac arrhythmias (torsades de pointes) via QT prolongation
Erythromycin	ABSOLUTE CONTRAINDICATION	Combined CYP3A4 inhibition significantly raises arrhythmia risk
Amiodarone	Caution — especially with high-dose (800mg) fluconazole	Additive QT prolongation risk
Warfarin	Monitor INR closely; reduce warfarin dose gradually	CYP2C9/CYP3A4 inhibition increases prothrombin time and bleeding risk
Apixaban, rivaroxaban (DOACs)	Monitor for bleeding	CYP3A4 inhibition raises DOAC blood levels
Phenytoin, carbamazepine	Monitor for toxicity/neurotoxicity	Increased antiepileptic drug levels via CYP inhibition
Cyclosporine, tacrolimus	Monitor drug levels closely	Increased immunosuppressant plasma concentration — toxicity risk
Atorvastatin, simvastatin, fluvastatin (statins)	Monitor for myopathy/rhabdomyolysis	Decreased statin metabolism via CYP3A4/CYP2C9 inhibition
Sulfonylureas (glipizide, glyburide)	Monitor blood glucose — hypoglycaemia risk	Reduced clearance of oral hypoglycaemic agents
Oral contraceptives	Generally no dose adjustment needed but be aware	At 200mg/day, increases ethinyl estradiol AUC by ~40% and levonorgestrel AUC by ~24%
Theophylline	Monitor theophylline levels	Fluconazole decreases theophylline clearance
Fentanyl / alfentanil	Monitor for respiratory depression	Delayed opioid elimination; fatal fentanyl toxicity case reported in literature
Rifampin (rifampicin)	May need fluconazole dose increase	Rifampin induces fluconazole metabolism, reducing its levels

 

The FDA label states plainly: “there is a risk of increased plasma concentration of other compounds metabolized by CYP2C9, CYP2C19, and CYP3A4 co-administered with fluconazole” beyond the specific interactions documented — meaning caution and monitoring should be applied broadly, not just to the specific drug names listed. Always provide your prescriber and pharmacist a complete, current medication list, including over-the-counter drugs and supplements. 

Pregnancy — A More Nuanced Picture Than “Discuss with Your Doctor” 

The source content advises a general conversation with your doctor about pregnancy, which is appropriate advice but omits substantial, specific, and evolving safety data that patients should be aware of when having that conversation: 

• High-dose, prolonged use: The FDA warned in 2011 that chronic use of fluconazole at 400–800mg/day during the first trimester may be associated with a specific pattern of birth defects termed “fluconazole embryopathy” — including craniosynostosis (abnormal skull bone fusion), characteristic facial features, digit fusion, limb contractures, and cleft palate. This pattern has been documented in case reports of infants exposed to prolonged high-dose therapy in utero. 
• Single low-dose (150mg) use — evolving evidence: A large Danish nationwide cohort study (published in JAMA, cited in the New England Journal of Medicine) found that oral fluconazole exposure in pregnancy — most commonly one or two 150mg doses — was associated with a statistically significant increased risk of spontaneous abortion (miscarriage) compared to unexposed women. The FDA reviewed this data and, as of its most recent public statements, has advised cautious prescribing of oral fluconazole in pregnancy, while also noting that available data do not provide definitive evidence of increased birth defect risk specifically from a single 150mg dose. 
• Tetralogy of Fallot signal: A large Danish registry study of 7,352 fluconazole-exposed pregnancies (mostly 150–300mg doses) found no increased risk of birth defects overall, but did identify a specific and statistically significant increased risk of tetralogy of Fallot (a specific congenital heart defect), with an adjusted odds ratio of 3.16. 
• Current clinical guidance: The U.S. Centers for Disease Control and Prevention (CDC) recommends using only topical antifungal products (such as clotrimazole or miconazole) for pregnant women with vaginal yeast infections, including for longer courses than usual if infections are persistent or recurrent — reserving oral fluconazole for situations where topical treatment is not appropriate or effective, and always with informed discussion of the evolving evidence above. 

Precautions and Warnings 

Allergy 

Do not take Fluconaz 200mg if you have a known hypersensitivity to fluconazole or other azole antifungal medications. 

Liver Disease 

Use with caution in patients with pre-existing liver disease, given the documented risk of hepatotoxicity. Periodic liver function monitoring is advisable, particularly with longer courses or higher doses. 

Kidney Disease 

Because fluconazole is cleared primarily by the kidneys, dose adjustment is necessary for multi-dose regimens in patients with impaired renal function (see Dosage table above). No adjustment is needed for the single-dose vaginal candidiasis regimen. 

Cardiac History 

Disclose any history of arrhythmia, QT prolongation, or use of other QT-prolonging medications before starting Fluconaz 200mg, given the cardiac risk detailed above. 

Breastfeeding 

Fluconazole is excreted into breast milk. Discuss the risks and benefits of continued breastfeeding with your healthcare provider if fluconazole therapy is needed. 

Storage Instructions 

• Store at room temperature, away from moisture and direct sunlight 
• Keep out of reach of children and pets 
• Check the expiry date before use 

Frequently Asked Questions (FAQs) 

What is Fluconaz 200mg used for? 

Fluconaz 200mg is used for a specific, FDA-defined list of fungal infections: oropharyngeal and esophageal candidiasis, systemic Candida infections, Candida urinary tract infections and peritonitis, and cryptococcal meningitis. Vaginal candidiasis specifically uses a different strength (150mg single dose), not the 200mg tablet discussed in this guide. 

Is it safe to use Fluconaz 200mg long-term without concern? 

No — this requires important qualification. Long-term or repeated use requires active monitoring for liver function abnormalities, and careful screening for drug interactions given fluconazole’s potent CYP450 enzyme inhibition, which becomes more clinically significant at doses of 200mg/day and above. It should never be characterised simply as “safe when monitored” without this specific context. 

Can I take Fluconaz 200mg during pregnancy? 

This requires an informed, individualised discussion with your doctor. Evidence suggests an increased risk of miscarriage with oral fluconazole exposure (even at commonly used single low doses), and high-dose prolonged use in the first trimester has been linked to a specific pattern of birth defects. Current guidance favours topical antifungal treatments for vaginal yeast infections during pregnancy where appropriate. 

Can I take Fluconaz 200mg with other medications? 

This requires careful review with your prescriber and pharmacist. Fluconazole has absolute contraindications with several drugs (including cisapride, pimozide, quinidine, and erythromycin) due to cardiac arrhythmia risk, and numerous other clinically significant interactions with blood thinners, statins, antiepileptic drugs, and immunosuppressants. Always provide a complete medication list before starting treatment. 

How long does it take for Fluconaz 200mg to work? 

For oropharyngeal candidiasis, clinical improvement is often seen within several days, though the full course (minimum 2 weeks) should be completed to reduce relapse risk. For more severe or systemic infections, resolution may take considerably longer, guided by clinical response and laboratory testing. 

 Medical Disclaimer 

All information in this guide is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Fluconaz 200mg is a prescription medication and should only be used under the supervision of a licensed healthcare provider. Never self-medicate or adjust your dose without medical guidance. In an emergency, contact local emergency services immediately. Report suspected adverse effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.